Free Trial

Capital Group Private Client Services Inc. Has $25.18 Million Stake in CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Capital Group Private Client Services Inc. lowered its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 4.2% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 108,411 shares of the financial services provider's stock after selling 4,785 shares during the period. Capital Group Private Client Services Inc.'s holdings in CME Group were worth $25,176,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of CME. Lake Street Advisors Group LLC lifted its position in CME Group by 108.7% in the 4th quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock valued at $2,949,000 after purchasing an additional 6,453 shares during the last quarter. Meyer Handelman Co. bought a new stake in shares of CME Group in the 4th quarter worth approximately $6,144,000. Unified Investment Management acquired a new stake in shares of CME Group during the 4th quarter valued at $503,000. Spire Wealth Management boosted its position in shares of CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider's stock valued at $307,000 after purchasing an additional 359 shares during the period. Finally, AEGON ASSET MANAGEMENT UK Plc boosted its holdings in shares of CME Group by 19.3% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider's stock worth $75,730,000 after buying an additional 52,862 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

Insider Buying and Selling at CME Group

In related news, insider Hilda Harris Piell sold 3,984 shares of the firm's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the completion of the transaction, the insider now owns 27,046 shares of the company's stock, valued at approximately $6,774,211.62. This trade represents a 12.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The stock was sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares of the company's stock, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is currently owned by corporate insiders.

CME Group Trading Down 0.8 %

Shares of CME stock traded down $2.20 on Monday, reaching $260.33. The company had a trading volume of 2,477,098 shares, compared to its average volume of 2,146,103. The stock has a market cap of $93.81 billion, a PE ratio of 26.92, a PEG ratio of 6.76 and a beta of 0.43. The company has a 50-day moving average of $257.19 and a 200-day moving average of $240.65. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $273.42.

CME Group (NASDAQ:CME - Get Free Report) last posted its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.92%. This is a boost from CME Group's previous quarterly dividend of $1.15. The ex-dividend date of this dividend was Friday, March 7th. CME Group's dividend payout ratio is presently 51.71%.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CME. Piper Sandler increased their price target on shares of CME Group from $275.00 to $283.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 8th. JPMorgan Chase & Co. upped their price target on CME Group from $209.00 to $212.00 and gave the stock an "underweight" rating in a research note on Thursday, February 13th. Oppenheimer lifted their price target on shares of CME Group from $269.00 to $279.00 and gave the company an "outperform" rating in a research report on Friday, April 11th. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $256.00 to $257.00 and gave the company a "market perform" rating in a research note on Friday, February 14th. Finally, Bank of America lifted their price target on CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $247.47.

Check Out Our Latest Stock Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines